WTN News FusionCIO Fusion Symposium Digital Healthcare Conference Blogs WTN Media Advertise

Home Page Subscribe Calendar IT Biotech Health Tech Careers Commentary Capital CIOs Visions More Topics…

Reproduction permitted for personal use only. For reprints and reprint permission, contact reprints@wistechnology.com.

Centrose announces drug-discovery patent

March 26, 2008

Madison, Wis. - Centrose, LLC, a Madison drug-discovery company, has announced that the United States Patent and Trademark Office has issued yet another patent for the University of Wisconsin-Madison spin off.

The patent, licensed through the Wisconsin Alumni Research Foundation, is used by Centrose and UW-Madison to discover drug-resistant strains of bacteria.

Centrose's drug improvement technologies have focused on how sugars regulate drug activity in the body.

The invention that led to issuance of the new patent was discovered by Centrose co-founder and UW-Madison professor Jon Thorson. The company is run by CEO James Prudent.

Related stories

• 2007 investment metrics: Angel network tracks $120M in venture deals

• Centrose secures $1.3M in capital from Milwaukee investors

• Centrose receives $190K in federal funding to automate drug discovery platform

Add Your Comment

Comment Policy: WTN News accepts comments that are on-topic and do not contain advertisements, profanity or personal attacks. Comments represent the views of the individuals who post them and do not necessarily represent the views of WTN Media or our partners, advertisers, or sources.

WTN Media cannot accept liability for the content of comments posted here or verify their accuracy. If you believe this comment section is being abused, contact edit@wistechnology.com.